These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Molecular diagnostics in pathology]. Stenzinger A; Penzel R; Endris V; Weichert W Dtsch Med Wochenschr; 2013 May; 138(20):1061-8. PubMed ID: 23670263 [TBL] [Abstract][Full Text] [Related]
3. Identification of Factors Affecting the Success of Next-Generation Sequencing Testing in Solid Tumors. Goswami RS; Luthra R; Singh RR; Patel KP; Routbort MJ; Aldape KD; Yao H; Dang HD; Barkoh BA; Manekia J; Medeiros LJ; Roy-Chowdhuri S; Stewart J; Broaddus RR; Chen H Am J Clin Pathol; 2016 Feb; 145(2):222-37. PubMed ID: 27124905 [TBL] [Abstract][Full Text] [Related]
4. Use of monoclonal antibodies to detect specific mutations in formalin-fixed, paraffin-embedded tissue sections. Guo Z; Lloyd RV Hum Pathol; 2016 Jul; 53():168-77. PubMed ID: 27083401 [TBL] [Abstract][Full Text] [Related]
5. Guidelines for cytogenetic investigations in tumours. Hastings RJ; Bown N; Tibiletti MG; Debiec-Rychter M; Vanni R; Espinet B; van Roy N; Roberts P; van den Berg-de-Ruiter E; Bernheim A; Schoumans J; Chatters S; Zemanova Z; Stevens-Kroef M; Simons A; Heim S; Salido M; Ylstra B; Betts DR; ; Eur J Hum Genet; 2016 Jan; 24(1):6-13. PubMed ID: 25804401 [No Abstract] [Full Text] [Related]
6. Comprehensive evaluation and validation of targeted next-generation sequencing performance in two clinical laboratories. Mendez P; Dang J; Kim JW; Lee S; Yoon JH; Kim T; Sailey CJ; Jablons DM; Kim IJ Int J Oncol; 2016 Jul; 49(1):235-42. PubMed ID: 27121194 [TBL] [Abstract][Full Text] [Related]
7. Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material. de Leng WW; Gadellaa-van Hooijdonk CG; Barendregt-Smouter FA; Koudijs MJ; Nijman I; Hinrichs JW; Cuppen E; van Lieshout S; Loberg RD; de Jonge M; Voest EE; de Weger RA; Steeghs N; Langenberg MH; Sleijfer S; Willems SM; Lolkema MP PLoS One; 2016; 11(2):e0149405. PubMed ID: 26919633 [TBL] [Abstract][Full Text] [Related]
8. Assessment of a fully automated high-throughput DNA extraction method from formalin-fixed, paraffin-embedded tissue for KRAS, and BRAF somatic mutation analysis. van Eijk R; Stevens L; Morreau H; van Wezel T Exp Mol Pathol; 2013 Feb; 94(1):121-5. PubMed ID: 22750048 [TBL] [Abstract][Full Text] [Related]
9. [Cytological material for molecular pathology]. Heukamp LC; Bubendorf L Pathologe; 2015 Nov; 36(6):566-71. PubMed ID: 26483251 [TBL] [Abstract][Full Text] [Related]
10. Next-generation sequencing of formalin-fixed, paraffin-embedded tumor biopsies: navigating the perils of old and new technology to advance cancer diagnosis. Latham GJ Expert Rev Mol Diagn; 2013 Nov; 13(8):769-72. PubMed ID: 24117229 [No Abstract] [Full Text] [Related]
11. Molecular Pathology: Prognostic and Diagnostic Genomic Markers for Myeloid Neoplasms. Kuo FC Surg Pathol Clin; 2016 Sep; 9(3):475-88. PubMed ID: 27523973 [TBL] [Abstract][Full Text] [Related]
13. TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy. Gray PN; Vuong H; Tsai P; Lu HM; Mu W; Hsuan V; Hoo J; Shah S; Uyeda L; Fox S; Patel H; Janicek M; Brown S; Dobrea L; Wagman L; Plimack E; Mehra R; Golemis EA; Bilusic M; Zibelman M; Elliott A Oncotarget; 2016 Oct; 7(42):68206-68228. PubMed ID: 27626691 [TBL] [Abstract][Full Text] [Related]
14. Peter C. Nowell (1928-2016). Greene MI; Moore JS Science; 2017 Mar; 355(6328):913. PubMed ID: 28254903 [No Abstract] [Full Text] [Related]
15. Cancer in the Renaissance court of Naples. Gaeta R; Giuffra V; Fornaciari G Lancet Oncol; 2017 Aug; 18(8):e432. PubMed ID: 28759378 [No Abstract] [Full Text] [Related]
16. KRAS mutation analysis in a complex molecular diagnostic referral practice: the need for test redundancy. Pang B; Ong CW; Chong ML; Muliana-Ismail T; Soong R; Salto-Tellez M Pathology; 2012 Dec; 44(7):655-7. PubMed ID: 23172084 [No Abstract] [Full Text] [Related]
17. Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics. Hirsch B; Endris V; Lassmann S; Weichert W; Pfarr N; Schirmacher P; Kovaleva V; Werner M; Bonzheim I; Fend F; Sperveslage J; Kaulich K; Zacher A; Reifenberger G; Köhrer K; Stepanow S; Lerke S; Mayr T; Aust DE; Baretton G; Weidner S; Jung A; Kirchner T; Hansmann ML; Burbat L; von der Wall E; Dietel M; Hummel M Virchows Arch; 2018 Apr; 472(4):557-565. PubMed ID: 29374318 [TBL] [Abstract][Full Text] [Related]
18. KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNA. Heideman DA; Lurkin I; Doeleman M; Smit EF; Verheul HM; Meijer GA; Snijders PJ; Thunnissen E; Zwarthoff EC J Mol Diagn; 2012; 14(3):247-55. PubMed ID: 22425762 [TBL] [Abstract][Full Text] [Related]
19. The Evolution of Pediatric Soft Tissue Sarcoma Classification in the Last 50 Years. Alaggio R; Coffin CM Pediatr Dev Pathol; 2015; 18(6):481-94. PubMed ID: 26701753 [TBL] [Abstract][Full Text] [Related]
20. The Molecular Diagnostics of Vascular Neoplasms. Habeeb O; Rubin BP Surg Pathol Clin; 2019 Mar; 12(1):35-49. PubMed ID: 30709447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]